Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong-Reference-Cited by-同舟云学术

Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong

Published:2019-01-14 Issue:3 Volume:22 Page:273-279
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Choon June W. Y.¹,Wu David B. C.¹²,Chong H. Y.¹,Lo William T. L.³,Chong Catherine S. Y.³,Chung W. S.⁴,Chui Eileena M. C.⁵,Tomlinson Brian⁶^ORCID,Lee Vivian W. Y.⁷,Lee S. C.⁶,Lee Kenneth K. C.¹^ORCID

Affiliation:

1. School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia;

2. Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO), Health and Well-being Cluster, Global Asia in the 21st Century (GA21) Platform, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia;

3. Kwai Chung Hospital, Hong Kong, PR China;

4. Tai Po Hospital, Hong Kong, PR China;

5. Queen Mary Hospital, Hong Kong, PR China;

6. Prince of Wales Hospital, Hong Kong, PR China;

7. School of Pharmacy, the Chinese University of Hong Kong, Hong Kong, PR China

Funder

This work was supported by an unrestricted educational grant from Johnson & Johnson (Hong Kong). Johnson & Johnson Hong Kong;

Publisher

Informa UK Limited

Subject

Health Policy

Link